Several tests in cultured cells indicated that ganciclovir would cause the death of HSV - TK - expressing stem cells, and testing in the mouse model confirmed that administration of the drug after successful treatment of
brain metastases successfully eliminated therapeutic stem cells that also expressed HSV - TK.